Form 4: Corcept Therapeutics Insider Sells Shares

Sentiment:

Insider Transaction (Form 4)


Sean Maduck, See Remarks of Corcept Therapeutics Inc, sold 25,000 shares of common stock on November 2, 2026.

Summary

  • Option exercise/conversion: acquired 11,841 Common Stock at $8.27 ($97,925) on November 2, 2026; holds 21,779 after (Direct).
  • Open-market sale: disposed of 11,841 Common Stock at $81.42 ($964,074) on November 2, 2026; holds 9,938 after (Direct).
  • Option exercise/conversion: acquired 13,159 Common Stock at $8.27 ($108,825) on November 3, 2026; holds 23,097 after (Direct).
  • Open-market sale: disposed of 8,617 Common Stock at $82.02 ($706,765) on November 3, 2026; holds 14,480 after (Direct).
  • Open-market sale: disposed of 4,542 Common Stock at $82.68 ($375,513) on November 3, 2026; holds 9,938 after (Direct).
  • Option exercise/conversion: disposed of 11,841 Stock option (right to buy) on November 2, 2026; holds 30,145 after (Direct).
  • Option exercise/conversion: disposed of 13,159 Stock option (right to buy) on November 3, 2026; holds 16,986 after (Direct).

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $2,046,351 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.

Insider Transactions

Sean Maduck — Other (See Remarks)

Transaction made under a Rule 10b5-1 trading plan.

DateTransactionSecuritySharesPriceValueHeld After
2026-11-02Option exercise/conversionCommon Stock11,841$8$97.9K21,779
2026-11-02Open-market saleCommon Stock11,841$81$964.1K9,938
2026-11-03Option exercise/conversionCommon Stock13,159$8$108.8K23,097
2026-11-03Open-market saleCommon Stock8,617$82$706.8K14,480
2026-11-03Open-market saleCommon Stock4,542$83$375.5K9,938
2026-11-02Option exercise/conversionStock option (right to buy)11,841——30,145
2026-11-03Option exercise/conversionStock option (right to buy)13,159——16,986

Key Dates

DateDescription
2026-11-02Option exercise/conversion (11,841 shares)
2026-11-02Open-market sale (11,841 shares)
2026-11-03Option exercise/conversion (13,159 shares)
2026-11-03Open-market sale (8,617 shares)
2026-11-03Open-market sale (4,542 shares)
2026-11-02Option exercise/conversion (11,841 shares)
2026-11-03Option exercise/conversion (13,159 shares)

Keywords

insider transaction, Form 4, CORT, CORCEPT THERAPEUTICS INC, bearish, Sean Maduck

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.